{'Year': '2020', 'Month': 'Sep'}
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
Evaluate the clinical utility of combinatorial pharmacogenomic testing for informing medication selection among older adults who have experienced antidepressant medication failure for major depressive disorder (MDD).